AIRLINK 78.39 Increased By ▲ 5.39 (7.38%)
BOP 5.34 Decreased By ▼ -0.01 (-0.19%)
CNERGY 4.33 Increased By ▲ 0.02 (0.46%)
DFML 30.87 Increased By ▲ 2.32 (8.13%)
DGKC 78.51 Increased By ▲ 4.22 (5.68%)
FCCL 20.58 Increased By ▲ 0.23 (1.13%)
FFBL 32.30 Increased By ▲ 1.40 (4.53%)
FFL 10.22 Increased By ▲ 0.16 (1.59%)
GGL 10.29 Decreased By ▼ -0.10 (-0.96%)
HBL 118.50 Increased By ▲ 2.53 (2.18%)
HUBC 135.10 Increased By ▲ 2.90 (2.19%)
HUMNL 6.87 Increased By ▲ 0.19 (2.84%)
KEL 4.17 Increased By ▲ 0.14 (3.47%)
KOSM 4.73 Increased By ▲ 0.13 (2.83%)
MLCF 38.67 Increased By ▲ 0.13 (0.34%)
OGDC 134.85 Increased By ▲ 1.00 (0.75%)
PAEL 23.40 Decreased By ▼ -0.43 (-1.8%)
PIAA 26.64 Decreased By ▼ -0.49 (-1.81%)
PIBTL 7.02 Increased By ▲ 0.26 (3.85%)
PPL 113.45 Increased By ▲ 0.65 (0.58%)
PRL 27.73 Decreased By ▼ -0.43 (-1.53%)
PTC 14.60 Decreased By ▼ -0.29 (-1.95%)
SEARL 56.50 Increased By ▲ 0.08 (0.14%)
SNGP 66.30 Increased By ▲ 0.50 (0.76%)
SSGC 10.94 Decreased By ▼ -0.07 (-0.64%)
TELE 9.15 Increased By ▲ 0.13 (1.44%)
TPLP 11.67 Decreased By ▼ -0.23 (-1.93%)
TRG 71.43 Increased By ▲ 2.33 (3.37%)
UNITY 24.51 Increased By ▲ 0.80 (3.37%)
WTL 1.33 No Change ▼ 0.00 (0%)
BR100 7,493 No Change 0 (0%)
BR30 24,558 No Change 0 (0%)
KSE100 72,052 No Change 0 (0%)
KSE30 23,808 No Change 0 (0%)
World

Pfizer-BioNTech to send 60 million doses to Turkey

  • Pfizer-BioNTech said the deal includes an option for 30 million doses that could bring the US-German venture's total deliveries to Turkey to 120 million doses this year.
Published May 20, 2021

ANKARA: Pfizer-BioNTech on Thursday announced a deal to deliver an additional 60 million doses of its vaccine to Turkey that could revive the tourism-dependent country's stalled innoculation drive.

Turkish Health Minister Fahrettin Koca said he hoped the new shipments could help the nation of 84 million to reach "collective immunity" by August.

Pfizer-BioNTech said the deal includes an option for 30 million doses that could bring the US-German venture's total deliveries to Turkey to 120 million doses this year.

BioNTech was founded by its current chief executive Ugur Sahin and his wife Ozlem Tureci -- both children of Turkish immigrants to Germany.

Sahin has spoken repeatedly about his desire to see Pfizer-BioNTech reach a large agreement with Turkey that could help it deal with the economic woes unleashed by the pandemic.

"We are grateful to be able to make an important contribution to Turkey's vaccination efforts and for the trust placed in us," he said in a statement Thursday.

NTV television said Sahin will sit in on a meeting of the Turkish health ministry's scientific council later Thursday.

Turkey is in danger of losing its second successive tourism season after witnessing its deadliest wave of the disease earlier this year.

Tourism indirectly accounts for up to 12 percent of the Turkish economy and is a key provider of foreign currency.

Turkey has managed to bring down the daily new infection numbers from 60,000 to around 10,000 after imposing its strictest lockdown of the pandemic last month.

Some of the toughest measures have been lifted but the entire country is still under full lockdown on weekends.

Turkey launched its vaccination drive with China's CoronaVac shot in mid-January and has since also reached a licensing and production agreement with Russia's Sputnik V.

But it has only administered the first dose to 15.6 million people and the full two doses to 11.7 million.

President Recep Tayyip Erdogan said he raised the issues of delays in promised CoronaVac deliveries during a visit by Chinese Foreign Minister Wang Yi in March.

Turkey has officially recorded more than 45,000 virus-related deaths and 5.2 million infections.

Comments

Comments are closed.